Discover the detailed record of transactions filed by Kelly Michael Aaron, Director. Insider active across 4 companies, notably DMC Global Inc.. Cumulatively, 13 filings have been recorded. The latest transaction was disclosed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is free.
Michael Aaron Kelly is a Director at DMC Global Inc., Neogenomics Inc., and Amicus Therapeutics, Inc. In this role, he participates in strategic decision-making and the direction of operations for these companies. Kelly brings his expertise to guide growth and innovation initiatives, thereby contributing to the success of each organization.